JP Morgan, Goldman Sachs & more: Top stocks on brokers' radar for today
Brokerage firms have varying outlooks on Indian companies. JP Morgan is underweight on Dr. Reddy's due to margin concerns, while Citigroup maintains a buy rating on Biocon despite weak numbers. Nomura is positive on Zydus Life following a key approval. Macquarie is underperforming on Swiggy, and Goldman Sachs has a buy rating on Pidilite, citing strong volume growth.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
